poisar

Stock

LifeStance Health Group, Inc. LFST

$12.70+3.89%

Overview

LFST market data

Price History

LFST price chart

Valuation & Profitability

Provider-backed
P/E (TTM)
195.99
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
$0.02
Diluted earnings per share over the trailing twelve months.
Beta
1.23
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
1.6%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$4.39 – $12.43
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $4.5B · P/B 1.80 · P/S 3.04.

Company News

10 captured
JP Morgan Maintains Neutral on LifeStance Health Gr, Raises Price Target to $13Benzinga · Aug 14, 2026, 4:04 PM
BTIG Maintains Buy on LifeStance Health Gr, Raises Price Target to $16Benzinga · Aug 7, 2026, 9:35 AM
LifeStance Health Group shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 sales guidance above estimates. Also, the company issued Q3 sales guidance above estimates.Benzinga · Aug 6, 2026, 11:49 AM
LifeStance Health Gr Sees Q3 Sales $420.000M-$440.000M vs $418.474M EstBenzinga · Aug 6, 2026, 10:15 AM
LifeStance Health Gr Raises FY2026 Sales Guidance from $1.640B-$1.680B to $1.685B-$1.725B vs $1.665B EstBenzinga · Aug 6, 2026, 10:15 AM
LifeStance Health Gr Q2 EPS $0.06 Beats $0.04 Estimate, Sales $435.354M Beat $414.577M EstimateBenzinga · Aug 6, 2026, 10:14 AM
BTIG Maintains Buy on LifeStance Health Gr, Raises Price Target to $15Benzinga · Jul 24, 2026, 10:22 AM
'Telehealth Firms Urge FDA to Legalize Peptides, With Guardrails' - BloombergBenzinga · Jul 23, 2026, 2:14 PM
Robinhood To Rally Around 24%? Here Are 10 Top Analyst Forecasts For TuesdayBenzinga · Jul 21, 2026, 11:51 AM
Canaccord Genuity Maintains Buy on LifeStance Health Gr, Raises Price Target to $13Benzinga · Jul 21, 2026, 11:36 AM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock